Increased C-reactive protein in ACE-inhibitor-induced angioedema

British Journal of Clinical Pharmacology

Volumn 59, Issue 2, 2005, Pages 233-238

  Bas, M ^a   Hoffmann, T K ^a   Bier, H ^a   Kojda, G ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acute phase proteins; Angioedema; Angiotensin converting enzyme inhibitor; C reactive protein

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; CLEMASTINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; FIBRINOGEN; HEMOGLOBIN; POTASSIUM; PREDNISOLONE; UREA;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BODY TEMPERATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; EMERGENCY WARD; FEMALE; FEVER; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TRACHEOSTOMY;

AGED; ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BODY TEMPERATURE; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FIBRINOGEN; HUMANS; LEUKOCYTE COUNT; MALE; RETROSPECTIVE STUDIES; SKIN TESTS;

EID: 13444257612     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02268.x     Document Type: Article

References (25)

1. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351: 1693-7.
2. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001; 24: 599-606.
3. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andren L, Wiholm BE. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. Bmj 1992; 304: 941-6.
4. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor - associated angioedema. JAMA 1997; 278: 232-3.
5. Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf 2002; 25: 73-6.
6. Molinaro G, Adam A, Lepage Y, Hammerschmidt D, Koenigbauer U, Eastlund T. Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation. Transfusion 2002; 42: 1458-65.
7. Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 2002; 359: 2088-9.
8. Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH, Brown NJ. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 2002; 39: 460-4.
9. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996; 60: 8-13.
10. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors, increased risk in patients of African origin. Br J Clin Pharmacol 1999; 48: 861-5.
11. Ajayi AA, Adigun AQ. Angioedema and cough in Nigerian patients receiving ACE inhibitors. Br J Clin Pharmacol 2000; 50: 81-2.
12. Ajayi AA, Oyewo EA, Ladipo CO, Akinsola A. Enalapril and hydrochlorothiazide in hypertensive Africans. Eur J Clin Pharmacol 1989; 36: 229-34.
13. Liu YH, Yang XP, Sharov VC, Nass O, Sabbah HN, Peterson E, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin 11 type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99: 1926-35.
14. Liu YH, Yang XP, Shesely EG, Sankey SS, Carretero OA. Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure. J Am Coll Cardiol 2004; 43: 1473-80.
15. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002; 347: 621-2.
16. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349: 1893-906.
17. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003; 34: 2922-9.
18. Joynt KE, Gattis WA, Hasselblad V, Fuzaylov SY, Serebruany VL, Gurbel PA, et al. Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. Am J Cardiol 2004; 93: 783-5.
19. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
20. Du Clos TW. C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum 2003; 48: 1475-7.
21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
22. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65.
23. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783-90.
24. Chen HM, Liao WS. Differential acute-phase response of rat kininogen genes involves type I and type II interleukin-6 response elements. J Biol Chem 1993; 268: 25311-19.
25. Wei W, Parvin N, Tsumura K, Akamatsu T, Tada J, Kanamori N, et al. Induction of C-reactive protein, serum amyloid P component, and kininogens in the submandibular and lacrimal glands of rats with experimentally induced inflammation. Life Sci 2001; 69: 359-68.